Cytomegalovirus infection and chronic graft-versus-host disease are significant predictors of renal failure after allogeneic hematopoietic stem cell transplantation

被引:0
|
作者
Deconinck, Eric [1 ,3 ,4 ,5 ]
Kribs, Marc [2 ]
Rebibou, Jean-Michel [2 ,3 ,4 ,5 ]
Bulabois, C. E. [6 ]
Ducloux, Didier [2 ,3 ,4 ,5 ]
Cahn, Jean-Yves [6 ]
机构
[1] CHRU Jean Minjoz, Hematol, Besancon, France
[2] CHRU St Jacques, Nephrol, Besancon, France
[3] INSERM, U645, Besancon, France
[4] Univ Besancon, Besancon, France
[5] BFC, EFS, Besancon, France
[6] CHRU Hop Nord Michallon, Oncol & Hematol, Grenoble, France
关键词
kidney failure; allogeneic hematopoietic stem cell transplantation; transplant complications; radiation injuries; late effects;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We investigated the frequencies and predictive factors of prolonged renal failure (PRF) in a retrospective study of 181 consecutive patients undergoing allogeneic hematopoietic stem cell transplantation. Twenty-six patients (23% of long-term survivors) developed PRF. We identified 4 independent prognostic factors; cytomegalovirus infection and chronic graft-versus-host disease appeared as major risk factors for PRF.
引用
收藏
页码:569 / 570
页数:3
相关论文
共 50 条
  • [41] Clinical significance of anti-endothelial cell antibody in allogeneic hematopoietic stem cell transplantation recipients with graft-versus-host disease
    Jianfeng Yao
    Axia Song
    Wenbin Cao
    Shulian Chen
    Lukun Zhou
    Shannan Cao
    Peng Liu
    Mei Wang
    Yuanfu Xu
    Aiming Pang
    Sizhou Feng
    Mingzhe Han
    International Journal of Hematology, 2014, 99 : 329 - 337
  • [42] Severity of Chronic Graft-versus-Host Disease and Late Effects Following Allogeneic Hematopoietic Cell Transplantation for Adults with Hematologic Malignancy
    Lee, Catherine J.
    Wang, Tao
    Chen, Karen
    Arora, Mukta
    Brazauskas, Ruta
    Spellman, Stephen R.
    Kitko, Carrie
    Macmillan, Margaret L.
    Pidala, Joseph A.
    Badawy, Sherif M.
    Bhatt, Neel
    Bhatt, Vijaya R.
    DeFilipp, Zachariah
    Diaz, Miguel A.
    Farhadfar, Nosha
    Gadalla, Shahinaz
    Hashmi, Shahrukh
    Hematti, Peiman
    Hossain, Nasheed M.
    Inamoto, Yoshihiro
    Lekakis, Lazaros J.
    Sharma, Akshay
    Solomon, Scott
    Lee, Stephanie J.
    Couriel, Daniel R.
    TRANSPLANTATION AND CELLULAR THERAPY, 2024, 30 (01): : 97.e1 - 97.e14
  • [43] Association of Chronic Graft-versus-Host Disease with Late Effects following Allogeneic Hematopoietic Cell Transplantation for Children with Hematologic Malignancy
    Lee, Catherine J.
    Wang, Tao
    Chen, Karen
    Arora, Mukta
    Brazauskas, Ruta
    Spellman, Stephen R.
    Kitko, Carrie
    MacMillan, Margaret L.
    Pidala, Joseph A.
    Auletta, Jeffery J.
    Badawy, Sherif M.
    Bhatt, Neel
    Bhatt, Vijaya R.
    Cahn, Jean-Yves
    DeFilipp, Zachariah
    Diaz, Miguel A.
    Farhadfar, Nosha
    Gadalla, Shahinaz
    Gale, Robert P.
    Hashem, Hasan
    Hashmi, Shahrukh
    Hematti, Peiman
    Hong, Sanghee
    Hossain, Nasheed M.
    Inamoto, Yoshihiro
    Lekakis, Lazaros J.
    Modi, Dipenkumar
    Patel, Sager
    Sharma, Akshay
    Solomon, Scott
    Couriel, Daniel R.
    TRANSPLANTATION AND CELLULAR THERAPY, 2022, 28 (10): : 712.e1 - 712.e8
  • [44] Epidemiology and Treatment of Chronic Graft-versus-Host Disease Post-Allogeneic Hematopoietic Cell Transplantation: A US Claims Analysis
    Bachier, Carlos R.
    Aggarwal, Sanjay K.
    Hennegan, Kalin
    Milgroom, Andrew
    Francis, Kevin
    Dehipawala, Sumudu
    Rotta, Marcello
    TRANSPLANTATION AND CELLULAR THERAPY, 2021, 27 (06): : 504.e1 - 504.e6
  • [45] Prediction of the risk for graft versus host disease after allogeneic hematopoietic stem cell transplantation in patients treated with mogamulizumab
    Kamada, Yuhei
    Arima, Naosuke
    Hayashida, Maiko
    Nakamura, Daisuke
    Yoshimitsu, Makoto
    Ishitsuka, Kenji
    LEUKEMIA & LYMPHOMA, 2022, 63 (07) : 1701 - 1707
  • [46] Incidence of refractory cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation
    Jinnouchi, Fumiaki
    Mori, Yasuo
    Yoshimoto, Goichi
    Yamauchi, Takuji
    Nunomura, Takuya
    Yurino, Ayano
    Hayashi, Masayasu
    Yuda, Junichiro
    Shima, Takahiro
    Odawara, Jun
    Takashima, Shuichiro
    Kamezaki, Kenjiro
    Kato, Koji
    Miyamoto, Toshihiro
    Akashi, Koichi
    Takenaka, Katsuto
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2022, 115 (01) : 96 - 106
  • [47] Incidence of refractory cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation
    Fumiaki Jinnouchi
    Yasuo Mori
    Goichi Yoshimoto
    Takuji Yamauchi
    Takuya Nunomura
    Ayano Yurino
    Masayasu Hayashi
    Junichiro Yuda
    Takahiro Shima
    Jun Odawara
    Shuichiro Takashima
    Kenjiro Kamezaki
    Koji Kato
    Toshihiro Miyamoto
    Koichi Akashi
    Katsuto Takenaka
    International Journal of Hematology, 2022, 115 : 96 - 106
  • [48] Vision-specific and cancer-specific quality of life in ocular graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
    Yinglin Liao
    Wenxin Zhao
    Jing Yang
    Shaowen Wu
    Ling Jin
    Fen Huang
    Lingyi Liang
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2023, 261 : 453 - 465
  • [49] Many Days at Home during Neutropenia after Allogeneic Hematopoietic Stem Cell Transplantation Correlates with Low Incidence of Acute Graft-versus-Host Disease
    Ringden, Olle
    Remberger, Mats
    Holmberg, Katarina
    Edeskog, Charlotta
    Wikstrom, Marie
    Eriksson, Britta
    Finnbogadottir, Sigrun
    Fransson, Karin
    Milovsavljevic, Ruza
    Omazic, Brigitta
    Svenberg, Petter
    Mattsson, Jonas
    Svahn, Britt-Marie
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (02) : 314 - 320
  • [50] Activated circulating dendritic cells after hematopoietic stem cell transplantation predict acute graft-versus-host disease
    Lau, Jenny
    Sartor, Mary
    Bradstock, Kenneth F.
    Vuckovic, Slavica
    Munster, David J.
    Hart, Derek N. J.
    TRANSPLANTATION, 2007, 83 (07) : 839 - 846